Renal Sarcoidosis-like Reaction Induced by PD-1 Inhibitor Treatment in Non-Small Cell Lung Cancer: A Case Report and Literature Review

被引:4
作者
Park, Sang-Don [1 ]
Kim, Mee-Seon [2 ]
Han, Man-Hoon [2 ]
Kim, Yong-Jin [2 ]
Jung, Hee-Yeon [1 ]
Choi, Ji-Young [1 ]
Cho, Jang-Hee [1 ]
Park, Sun-Hee [1 ]
Kim, Chan-Duck [1 ]
Kim, Yong-Lim [1 ]
Lim, Jeong-Hoon [1 ]
机构
[1] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Div Nephrol, Daegu 41944, South Korea
[2] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Pathol, Daegu 41944, South Korea
来源
MEDICINA-LITHUANIA | 2023年 / 59卷 / 05期
基金
新加坡国家研究基金会;
关键词
sarcoidosis-like reaction; immune checkpoint inhibitor; PD-1; inhibitor; kidney biopsy; lung cancer; IPILIMUMAB; BLOCKADE;
D O I
10.3390/medicina59050991
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Monoclonal antibodies directed against immune checkpoint proteins have been widely used to treat various cancers and have resulted in favorable clinical outcomes. Despite these beneficial properties, immune checkpoint inhibitors (ICIs) can induce side effects called immune-related adverse events, including sarcoidosis-like reactions (SLR) across multiple organs. Here, we report a case of renal SLR after ICI treatment, and we review the related literature. A 66-year-old Korean patient with non-small cell lung cancer was referred to the nephrology clinic for renal failure after the 14th pembrolizumab treatment dose. A renal biopsy revealed multiple epithelioid cell granulomas, with several lymphoid aggregates in the renal interstitium and a moderate degree of inflammatory cell infiltration in the tubulointerstitium. A moderate dose of steroid therapy was initiated, and the serum creatinine level partially recovered after four weeks of treatment. Judicious monitoring of renal SLR is, therefore, required during ICI therapy, and a timely diagnosis by renal biopsy and appropriate treatment are important.
引用
收藏
页数:8
相关论文
共 28 条
[1]   Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC [J].
Antonia, S. J. ;
Villegas, A. ;
Daniel, D. ;
Vicente, D. ;
Murakami, S. ;
Hui, R. ;
Kurata, T. ;
Chiappori, A. ;
Lee, K. H. ;
de Wit, M. ;
Cho, B. C. ;
Bourhaba, M. ;
Quantin, X. ;
Tokito, T. ;
Mekhail, T. ;
Planchard, D. ;
Kim, Y. -C. ;
Karapetis, C. S. ;
Hiret, S. ;
Ostoros, G. ;
Kubota, K. ;
Gray, J. E. ;
Paz-Ares, L. ;
Carpeno, J. de Castro ;
Faivre-Finn, C. ;
Reck, M. ;
Vansteenkiste, J. ;
Spigel, D. R. ;
Wadsworth, C. ;
Melillo, G. ;
Taboada, M. ;
Dennis, P. A. ;
Ozguroglu, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (24) :2342-2350
[2]   Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway [J].
Boussiotis, Vassiliki A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (18) :1767-1778
[3]   Nivolumab Plus Ipilimumab in Patients With Advanced Melanoma: Updated Survival, Response, and Safety Data in a Phase I Dose-Escalation Study [J].
Callahan, Margaret K. ;
Kluger, Harriet ;
Postow, Michael A. ;
Segal, Neil H. ;
Lesokhin, Alexander ;
Atkins, Michael B. ;
Kirkwood, John M. ;
Krishnan, Suba ;
Bhore, Rafia ;
Horak, Christine ;
Wolchok, Jedd D. ;
Sznol, Mario .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04) :391-+
[4]   Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper [J].
Champiat, S. ;
Lambotte, O. ;
Barreau, E. ;
Belkhir, R. ;
Berdelou, A. ;
Carbonnel, F. ;
Cauquil, C. ;
Chanson, P. ;
Collins, M. ;
Durrbach, A. ;
Ederhy, S. ;
Feuillet, S. ;
Francois, H. ;
Lazarovici, J. ;
Le Pavec, J. ;
De Martin, E. ;
Mateus, C. ;
Michot, J. -M. ;
Samuel, D. ;
Soria, J. -C. ;
Robert, C. ;
Eggermont, A. ;
Marabelle, A. .
ANNALS OF ONCOLOGY, 2016, 27 (04) :559-574
[5]   Immune checkpoint inhibitore-associated sarcoidosis: A usually benign disease that does not require immunotherapy discontinuation [J].
Chanson, Noemie ;
Ramos-Casals, Manuel ;
Pundole, Xerxes ;
Suijkerbuijk, Karijn ;
de Barros e Silva, Milton Jose ;
Lidar, Merav ;
Benesova, Karolina ;
Leipe, Jan ;
Acar-Denizli, Nihan ;
Pradere, Pauline ;
Michot, Jean-Marie ;
Voisin, Anne-Laure ;
Suarez-Almazor, Maria E. ;
Radstake, Timothy R. D. ;
Trevisani, Virginia Fernandes Moca ;
Schulze-Koops, Hendrik ;
Melin, Audrey ;
Robert, Caroline ;
Mariette, Xavier ;
Baughman, Robert P. ;
Lambotte, Olivier .
EUROPEAN JOURNAL OF CANCER, 2021, 158 :208-216
[6]   Immune Checkpoint Inhibitor-Associated Sarcoidosis Reaction in the Kidney: Case Report [J].
Charkviani, Mariam ;
Herrmann, Sandra M. .
KIDNEY MEDICINE, 2023, 5 (05)
[7]   Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors [J].
Cortazar, Frank B. ;
Marrone, Kristen A. ;
Troxell, Megan L. ;
Ralto, Kenneth M. ;
Hoenig, Melanie P. ;
Brahmer, Julie R. ;
Le, Dung T. ;
Lipson, Evan J. ;
Glezerman, Ilya G. ;
Wolchok, Jedd ;
Cornell, Lynn D. ;
Feldman, Paul ;
Stokes, Michael B. ;
Zapata, Sarah A. ;
Hodi, F. Stephen ;
Ott, Patrick A. ;
Yamashita, Michifumi ;
Leaf, David E. .
KIDNEY INTERNATIONAL, 2016, 90 (03) :638-647
[8]   Immune checkpoint inhibitors: recent progress and potential biomarkers [J].
Darvin, Pramod ;
Toor, Salman M. ;
Nair, Varun Sasidharan ;
Elkord, Eyad .
EXPERIMENTAL AND MOLECULAR MEDICINE, 2018, 50 :1-11
[9]   Sarcoidosis is a Th1/Th17 multisystem disorder [J].
Facco, Monica ;
Cabrelle, Anna ;
Teramo, Antonella ;
Olivieri, Valeria ;
Gnoato, Marianna ;
Teolato, Sara ;
Ave, Elisa ;
Gattazzo, Cristina ;
Fadini, Gian Paolo ;
Calabrese, Fiorella ;
Semenzato, Gianpietro ;
Agostini, Carlo .
THORAX, 2011, 66 (02) :144-150
[10]   Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer [J].
Garon, Edward B. ;
Rizvi, Naiyer A. ;
Hui, Rina ;
Leighl, Natasha ;
Balmanoukian, Ani S. ;
Eder, Joseph Paul ;
Patnaik, Amita ;
Aggarwal, Charu ;
Gubens, Matthew ;
Horn, Leora ;
Carcereny, Enric ;
Ahn, Myung-Ju ;
Felip, Enriqueta ;
Lee, Jong-Seok ;
Hellmann, Matthew D. ;
Hamid, Omid ;
Goldman, Jonathan W. ;
Soria, Jean-Charles ;
Dolled-Filhart, Marisa ;
Rutledge, Ruth Z. ;
Zhang, Jin ;
Lunceford, Jared K. ;
Rangwala, Reshma ;
Lubiniecki, Gregory M. ;
Roach, Charlotte ;
Emancipator, Kenneth ;
Gandhi, Leena .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (21) :2018-2028